European Archives - Page 827 of 1165 - European Medical Journal

Low Oxygen Concentration and Thrombosis

Hypoxia is commonly found in a number of disorders, including cancers, alcoholism, sickle cell anaemia, and nonalcoholic fatty liver disease. The oxygen…

New Scale Helps Match Patients to the Optimal Cancer Therapy

Targeted cancer treatment options should become more simplified and standardised following the creation of a new scale for tumour DNA mutations that has…

Gut Enzymes Could Make Any Blood Type Universally Available

Blood could become far more accessible following the discovery of a group of enzymes that are able to turn any type of blood into type O, which can be…

Early Detection of Vascular Diseases Can be Achieved Through Ultrasound Imaging

Vascular diseases can be detected before symptoms appear on ultrasound images of arteries, according to researchers from the University of…

Innovative Technique Can Predict Response to Lymphoma Therapy

Response to therapy in diffuse large B cell lymphoma patients can be assessed quickly by measuring changes in circulating tumour DNA (ctDNA) levels…

Overall Decline in Death Rates from Stroke in Europe

Mortality rates from three forms of stroke are declining overall in Europe, according to a study presented in a European Society of Cardiology (ESC)…

Women’s Chances of Long and Healthy Lives Affected by Parental Lifespan

Women are 25% and 38% more likely to enjoy long and healthy lives if either their mother or both of their parents, respectively, live to at least the age…

Higher BMI Linked to Preference for Evening Activity in Prediabetes

People with prediabetes have a higher BMI if they are more active later in the day, the so-called evening preference, according to a study led by the…

Exercise Improves Symptoms in Chronic Kidney Disease Patients

Chronic kidney disease (CKD) patients can significantly ease their symptoms and enhance their quality of life by engaging in both aerobic and strength…

BAN2401 Shows Promising Results for the Treatment of Alzheimer’s Disease

BAN2401, a humanised monoclonal antibody that selectively binds to and eliminates soluble amyloid-β aggregates, has been shown to have statistically…